Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL330 Target Snapshot

Glutamate receptor ionotropic, NMDA 1 · SINGLE PROTEIN · Rattus norvegicus

1,966Compounds
116Assays
3Approved Drugs
856.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P35439. Use UniProt P35439 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P35439 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Glutamate receptor ionotropic, NMDA 1 as ChEMBL target CHEMBL330, mapped to UniProt P35439. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Glutamate receptor ionotropic, NMDA 1
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL330
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P35439
Glutamate receptor ionotropic, NMDA 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Glutamate receptor ionotropic, NMDA 1 is the right protein anchor across sources, using UniProt P35439 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGlutamate receptor ionotropic, NMDA 1
UniProt AccessionP35439
Component TypeProtein
Sequence Length938 aa

Glutamate receptor ionotropic, NMDA 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Glutamate receptor ionotropic, NMDA 1, mapped to UniProt P35439. Sequence length is 938 aa.

Mapped IDP35439
Review nameGlutamate receptor ionotropic, NMDA 1
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

3
Approved
1
Phase III
5
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC50474.0
KI355.0
EC5027.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL31741 9.0 Ki 1.0 Preclinical
CHEMBL349136 9.0 Ki 1.0 Preclinical
CHEMBL85567 9.0 IC50 1.0 Preclinical
CHEMBL161406 8.92 IC50 1.2 Preclinical
CHEMBL117627 8.9 Ki 1.259 Preclinical
CHEMBL289151 8.85 Ki 1.4 Preclinical
CHEMBL32076 8.85 IC50 1.4 Preclinical
CHEMBL350974 8.82 IC50 1.5 Preclinical
CHEMBL117691 8.8 Ki 1.585 Preclinical
CHEMBL168394 8.7 Ki 1.995 Preclinical
Distribution

pChEMBL Value Distribution

117
5.0
93
5.5
100
6.0
87
6.5
66
7.0
60
7.5
48
8.0
21
8.5
3
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

GLYCINE
CHEMBL773
Approved 1982
Assay Landscape

Assay Landscape

116
Total Assays
632
Tested Compounds
2
Assay Types
Binding — 105 assays, 632 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 39 208 6.2
cell membrane format 34 257 6.4
assay format 18 95 5.6
tissue-based format 12 72 6.5
cell-based format 1 0
organism-based format 1 0
Functional — 11 assays, 12 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 8 12 7.8
cell-based format 3 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine